Christina Cobb
Family · Honesdale, PANPI 1215304043
Payments from drug & device makers
Across 357 payments — averaging $23.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Boehringer Ingelheim$545
- Actelion Pharmaceuticals US, Inc.$319
- Sanofi$309
- Sanofi-aventis U.S. LLC$257
- plus $2K from 31 others
What the payments were for
- Food & beverage$7,87996%
- Education$3714%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 120 | $3,296 |
| GSK | 85 | $1,676 |
| Boehringer Ingelheim | 27 | $545 |
| Actelion Pharmaceuticals US, Inc. | 7 | $319 |
| Sanofi | 13 | $309 |
| Sanofi-aventis U.S. LLC | 3 | $257 |
| Philips North America LLC | 12 | $221 |
| Verona Pharma, Inc. | 12 | $197 |
| Regeneron Healthcare Solutions, Inc. | 10 | $162 |
| Vifor Pharma, Inc. | 5 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $121 |
| Amgen | 5 | $111 |
| Grifols USA, LLC | 6 | $111 |
| Novartis | 6 | $110 |
| Genentech USA, Inc. | 5 | $99 |
| Insmed, Inc. | 5 | $90 |
| Johnson & Johnson | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $42 |
| Mylan Specialty L.p. | 2 | $42 |
| AbbVie | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $23 |
| Baxter Healthcare | 1 | $20 |
| Advanced Respiratory, Inc | 1 | $18 |
| Viatris Specialty LLC | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Vapotherm Inc | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
| Electromed, Inc. | 1 | $15 |
| Watermark Medical, Inc. | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
| Scpharmaceuticals Inc. | 1 | $15 |
| ANI Pharmaceuticals, Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,250 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 439 | $411,093 |
| OfevNintedanib Esylate | 11 | $142,395 |
| Breo ElliptaFluticasone/Vilanterol | 249 | $136,470 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 148 | $135,834 |
| Dupixent PenDupilumab | 28 | $109,463 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 133 | $78,259 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 62 | $41,331 |
| Dupixent SyringeDupilumab | 12 | $41,207 |
| XolairOmalizumab | 13 | $35,001 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 113 | $23,111 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 569 | $20,736 |
| DuleraMometasone/Formoterol | 27 | $17,511 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 27 | $16,068 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 103 | $15,711 |
| Advair HfaFluticasone Propion/Salmeterol | 33 | $14,091 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $1,676 | $635,335846 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Combivent Respimat | $545 | $199,793100 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $3,296 | $153,240200 claims |
| MerckDulera | $12 | $17,51127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.
Other family in Honesdale
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.